Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SPARC and BSE: 532872 (ISIN INE232I01014).
It has a market capitalisation of ₹6,006 crore, a last close of ₹185.07 on 2026-10-19, a one-year return of 43.0%.
Valuation: a price-to-earnings ratio of 3.79x, a price-to-book ratio of 4.50x, a dividend yield of 0.0%.
Profitability: return on equity of 278.9%, return on capital employed of 232.1%, an operating margin of 84.6%.
Growth: sales growth of 98.9% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.42x, promoter holding of 65.7%.
| Metric | Value |
|---|---|
| Market capitalisation | 6,006 |
| Last close | ₹185.07 |
| P/E (TTM) | 3.79x |
| P/B | 4.50x |
| Dividend yield | 0.0% |
| ROE (FY) | 278.9% |
| ROCE (FY) | 232.1% |
| Operating margin (TTM) | 84.6% |
| Sales growth, 3-year CAGR | 98.9% |
| Debt / equity | 0.42x |
| Promoter holding | 65.7% |
| 1-year return | 43.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means